News

A recent case report highlights that repeated bone fractures can be a warning sign of systemic mastocytosis (SM).

A review examines decades of research on mast cells and their diversity, explaining why these key cells in SM are hard to study.

Though uncommon, advanced SM can cause severe gastrointestinal distress with no skin issues, making diagnosis a challenge.

A small-scale study in Turkey evaluated sleep studies of nine patients with SM, observing potential sleep-related burden in some individuals.

An 81-year old woman with a highly complex case of mast cell leukemia demonstrated the importance of tailored care.

Extensive evaluation helped doctors distinguish between exercise-induced anaphylaxis and mast cell disorders like SM and MCAS.

A PROSPECTOR analysis found that tryptase levels in clonal mast cell disease often fell below the cutoff used to support an SM diagnosis.

Analysis showed avapritinib helped alleviate cutaneous involvement, including skin lesions, in both indolent and advanced forms of SM.

Once poorly understood, SM is now recognized as a type of blood cancer that can be treated with targeted therapies.

People without medical training can correctly use neffy, a needle-free epinephrine nasal spray for severe allergic reactions.